Radley S C, Chapple C R, Mitsogiannis I C, Glass K S
Department of Urology, Royal Hallamshire Hospital, Sheffield, UK.
Eur Urol. 2001 Apr;39(4):383-9. doi: 10.1159/000052474.
To assess the results of transurethral implantation of Macroplastique in women with stress incontinence secondary to urethral sphincter deficiency using subjective and objective outcome measures.
A total of 60 women with genuine stress incontinence secondary to intrinsic urethral sphincter deficiency were treated with transurethral implantation of Macroplastique. The patients had undergone a mean of 1.9 (range 0-7) previous episodes of continence surgery. Up to three treatment episodes were used, if necessary. The outcome was assessed by telephone interview (56 patients, mean follow-up period 19 months) and videocystometry (41 patients, mean follow-up period 16 months). Transurethral ultrasound scanning was performed in a further 9 patients.
Symptomatically, 19.6% of the women interviewed by telephone considered themselves cured of their incontinence or were no longer using pads. A further 41.1% said their symptoms had significantly improved. Pad usage was reduced from a median of five to three pads per day (p < 0.001). Videocystometry in 41 women (mean follow-up period 16 months) was normal in 16 patients (39%) and showed genuine stress incontinence in 18 (43.9%) and detrusor instability in 12 patients (29.3%). Overall, 71.4% stated that they would undergo the procedure again under the same circumstances, and 80.4% would recommend this form of treatment to a friend with the same condition. Transurethral ultrasound scanning was performed in 9 patients (5 subjectively improved or cured, 1 patient with persistent symptoms but normal cystometry, and 3 patients with persistent genuine stress incontinence). Hyperechoic foci were seen surrounding the proximal urethra, consistent with implanted Macroplastique boluses. When completely encircling the urethra, the outcome was generally good. A total of 10 patients have undergone or are awaiting open surgery, and 3 are awaiting repeat implantation.
Sustained improvement or cure of genuine stress incontinence has been achieved using Macroplastique in a large proportion of women with intrinsic sphincter deficiency, often following previous unsuccessful continence surgery. Transurethral ultrasound may prove to be a clinically useful imaging technique for the assessment and subsequent management of treatment failure following Macroplastique implantation.
采用主观和客观的结局指标,评估经尿道植入Macroplastique治疗尿道括约肌功能不全所致压力性尿失禁女性患者的效果。
共有60例因固有尿道括约肌功能不全导致真性压力性尿失禁的女性患者接受了经尿道Macroplastique植入治疗。这些患者此前平均接受过1.9次(范围0 - 7次)控尿手术。必要时可进行多达三次治疗。通过电话访谈(56例患者,平均随访期19个月)和膀胱测压(41例患者,平均随访期16个月)评估结局。另外9例患者进行了经尿道超声扫描。
在接受电话访谈的女性中,19.6%认为自己的尿失禁已治愈或不再使用尿垫。另有41.1%表示症状显著改善。尿垫使用量从每天中位数5片减少至3片(p < 0.001)。41例女性(平均随访期16个月)的膀胱测压结果显示,16例(39%)正常,18例(43.9%)为真性压力性尿失禁,12例(29.3%)为逼尿肌不稳定。总体而言,71.4%表示在相同情况下会再次接受该手术,80.4%会向患有相同疾病的朋友推荐这种治疗方式。9例患者进行了经尿道超声扫描(5例主观症状改善或治愈,1例症状持续但膀胱测压正常,3例持续存在真性压力性尿失禁)。在尿道近端周围可见高回声灶,与植入的Macroplastique团块一致。当完全环绕尿道时,结局通常较好。共有10例患者已接受或正在等待开放性手术,3例正在等待再次植入。
对于大多数固有括约肌功能不全的女性患者,使用Macroplastique可实现真性压力性尿失禁的持续改善或治愈,这些患者此前的控尿手术往往失败。经尿道超声可能是评估Macroplastique植入后治疗失败及后续管理方面具有临床实用价值的成像技术。